Almawave and Vivisol: together to bring Artificial Intelligence to home care
18 October 2021
“AI is fundamental to achieving the strategic objectives of the PNRR in healthcare,” says Valeria Sandei, CEO of Almawave.
Almawave, an Italian company listed on AIM Italia and a leader in AI for natural language analysis and Big Data services, and Vivisol, part of the Sol Group—whose parent company SOL Spa has been listed on the Milan Stock Exchange since 1998 and is one of the main European players in home healthcare, providing complex healthcare services and therapies—announce a collaboration agreement.
This partnership, the first of its kind at the national level, aims to develop AI solutions applied to home care, with the broader goal of promoting de-hospitalization and ensuring patients receive adequate and effective therapeutic care at home. Almawave and Vivisol have already started collaborating since last April on the RicovAI-19 project, carried out with the Ospedali Riuniti di Ancona. Thanks to the so-called Clinical Stability Indicator (AI-CSI) developed by Almawave, the project allowed continuous home monitoring of 150 patients, providing treating physicians with an innovative tool to support clinical and therapeutic decisions.
